Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
October 28, 2024 05:51 ET
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], announced that it has...
Smart Immune détermine la dose recommandée de SMART101 pour ses essais cliniques en oncologie
October 23, 2024 01:01 ET
|
Smart Immune
La phase I d'escalade de dose de ReSET-02 chez des adultes souffrant de cancers hématologiques est terminée.Le segment randomisé de la phase II de cet essai est en cours.Aucune toxicité limitant la...
Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials
October 23, 2024 01:01 ET
|
Smart Immune
ReSET-02 dose escalation Phase I is completedPhase II PoC randomized segment is starting No dose-limiting toxicities, no safety or tolerability issuesThe highest dose is to be used in both...
Nodenza Venture Partners invests in Trellis Bioscience
October 22, 2024 07:00 ET
|
Nodenza Venture Partners
Nodenza Venture Partners invests in Trellis Bioscience Lead product TRL1068 targets biofilm, estimated to cause 60-70% of antibiotic resistant infections New York, October 22, 2024 – Nodenza...
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
October 16, 2024 07:00 ET
|
Nodenza Venture Partners
Nodenza Venture Partners launched Focus on international early-stage and pre-commercial biotech & medtech opportunities New York, October 16, 2024 – Nodenza Venture Partners (“Nodenza”) has been...
Forbion raises in excess of €2 billion for two new funds
October 15, 2024 01:00 ET
|
Forbion
Forbion’s largest fundraising to date with Forbion’s Growth Opportunities Fund III raising €1.2 billion & Forbion Ventures Fund VII raising €890 million
Kneat Announces Closing of $35.6 Million Bought Deal
October 10, 2024 10:17 ET
|
kneat.com, inc.
Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million.
Curia Commits to SBTi Net-Zero Standard
October 08, 2024 09:00 ET
|
Curia Global, Inc.
Curia today announced its commitment to set near- and long-term greenhouse gas reductions in line with the Science Based Targets initiative (SBTi).
Sai Life Sciences releases Sustainability Report 2024
October 07, 2024 05:03 ET
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its...
KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight
September 30, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight According to DelveInsight’s analysis, the growth of the KRAS...